Correlation of SD-OCT features and retinal sensitivity in neovascular age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 10, 2012, Pages 6448-6455

  Sulzbacher, Florian ^a   Kiss, Christopher ^a   Kaider, Alexandra ^a   Eisenkoelbl, Stefan ^a   Munk, Marion ^a   Roberts, Philipp ^a   Sacu, Stefan ^a   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMICROSCOPY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUSEN; EXUDATIVE MACULAR DEGENERATION; HUMAN; IMAGE ANALYSIS; OPHTHALMOSCOPY; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA DETACHMENT; RETINAL SENSITIVITY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISION TEST; CLINICAL TRIAL; COMPUTER PROGRAM; EXUDATE; EYE FUNDUS; IMAGE PROCESSING; INFRARED RADIATION; METHODOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PERIMETRY; PHOTOGRAPHY; PROGNOSIS; RETINA MACULA DEGENERATION; SEVERITY OF ILLNESS INDEX; VISUAL ACUITY;

DIAGNOSTIC AGENT;

CHOROIDAL NEOVASCULARIZATION; EXUDATES AND TRANSUDATES; FUNDUS OCULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFRARED RAYS; MACULAR DEGENERATION; PHOTOGRAPHY; PROGNOSIS; RETINAL DETACHMENT; RETINAL DRUSEN; SEVERITY OF ILLNESS INDEX; SOFTWARE; TOMOGRAPHY, OPTICAL COHERENCE; VISION TESTS; VISUAL ACUITY; VISUAL FIELD TESTS;

EID: 84871853851     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-9162     Document Type: Article

References (24)

1. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
2. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
3. Grossniklaus HE, Gass JD. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol. 1998;126:59-69.
4. Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina. 2010;30:1333-1349.
5. Sayanagi K Sharma S, Yamamoto T, et al. Comparision of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology. 2009;116:947-955.
6. Schmidt-Erfurth U, Richard G, Augustin A, et al. Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand. 2007;85:486-494.
7. Springer C, Völcker HE, Rohrschneider K. Statische Fundusperimetrie bei Probanden Microperimeter 1 versus SLO. Opthalmologe. 2006;103:214-220.
8. Midena E, Vujosevic S, Cavarzeran F, et al. Normal values for fundus perimetry with the microperimeter MP1. Ophthalmology. 2010;117:1571-1576.
9. Charbel Issa P, Troeger E, Finger R, et al. Structure-function correlation of the human central retina. PloS ONE. 2010;22: e12864.
10. Landa G, Su E, Garcia P, et al. Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina. 2011;31:364-370.
11. Kashani AH, Keane PA, Dustin L, et al. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50:3366-3373.
12. Browning DJ, Glassman AR, Aiello LP, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Opthalmology. 2007;114:525-536.
13. Lalwani GA, Rosenfeld PJ, Fung AE, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular agerelated macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol. 2009;148:43-58. e41.
14. Nilsson UL, Frennesson C, Nilsson SE. Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser ophthalmoscope. Vision Res. 2003;43:1777-1787.
15. Calabrese A, Bernard JB, Hoffart L, et al. Wet versus dry agerelated macular degeneration in patients with central field loss: different effects on maximum reading speed. Invest Ophthalmol Vis Sci. 2011;52:2417-2424.
16. Moutray T, Alarbi M, Mahon G, et al. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularization. Br J Ophthalmol. 2008;92:361-364.
17. Deak G, Bolz M, Ritter M, et al. A systematic correlation of morphology and functional alterations in diabetic macular edema. Invest Ophthalmol Vis Sci. 2010;9:50-64.
18. Keane PA, Liakopoulos S, Chang KT, et al. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology. 2008;115:2206-2214.
19. Ahlers C, Golbaz I, Stock G, et al. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration. Ophthalmology. 2008;115:39-46.
20. Parravano M, Oddone F, Tedeschi M, et al. Retinal functional changes measured by microperimetry in neovascular agerelated macular degeneration treated with ranibizumab: 24-months results. Retina. 2010;30:1017-1024.
21. Kiss CG, Geitzenauer W, Simader C, et al. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function. Invest Ophthalmol Vis Sci. 2009;50:2376-2383.
22. Hayashi H, Yamashiro K, Tsujikawa A, et al. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol. 2009;148:83-89.
23. Oishi A, Hata M, Shimozono M, et al. The significance of external limiting membrane status for visual acuity in agerelated macular degeneration. Am J Ophthalmol. 2010;150: 27-32.
24. Srauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845-881.